![](https://ml.globenewswire.com/media/424c2f93-0321-4df2-98b6-6a7970d20bd4/small/primarylogo-mango-05-png.png)
MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology
Dallas, Texas, July 24, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a leader in men’s health and wellness products including erectile dysfunction (ED), hair growth, weight loss, and hormone replacement …